Clinical Care and Education

DC2428 - All Things New: Hot topics from 2024

Speaker(s)

• 

  Harpreet Singh Bajaj, MD, MPH, FACE

  Endocrinologist and Director of Late-Phase Research
  LMC Healthcare, Canada
  Brampton, Ontario, Canada

  Disclosure information not submitted.
• 

  Alice YY Cheng, Asoociate Professor (she/her/hers)

  Dr. Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associat
  University of Toronto
  University of Toronto
  Toronto, Ontario, Canada

  Disclosure(s): Abbott Diabetes: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Amgen: Speaker/Honoraria (Ongoing); Astra Zeneca: Speaker/Honoraria (Ongoing); Bayer Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly & Company: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); GlaxoSmithKline: Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Janssen: Advisory Board (Ongoing); Medtronic: Speaker/Honoraria (Ongoing); Novo Nordisk A/S: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk Canada Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Speaker/Honoraria (Ongoing); Sanofi: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing)
• JK

  James W. Kim, MBBCh, PgDip, MScCH (he/him/his)

  Clinical Assistant Professor
  University of Calgary
  University of Calgary
  Calgary, Alberta, Canada

  Disclosure(s): Abbott Diabetes: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Abbvie: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Speaker/Honoraria (Ongoing); Eisai: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly Canada: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); EMBECTA: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); GSK: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Idorsia: Consultant (Ongoing); Lin Pharma: Advisory Board (Ongoing); MDBriefcase: Committee/Planning Member (Terminated); Novo Nordisk Canada: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Otsuka: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Pfizer: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Searchlight: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Takeda Canada: Advisory Board (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Teva: Speaker/Honoraria (Ongoing)

Moderator(s)

• 

  Baiju R. Shah, MD PhD (he/him/his)

  Professor
  University of Toronto
  University of Toronto
  Toronto, Ontario, Canada

  Disclosure information not submitted.